JP2014221816A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014221816A5 JP2014221816A5 JP2014148568A JP2014148568A JP2014221816A5 JP 2014221816 A5 JP2014221816 A5 JP 2014221816A5 JP 2014148568 A JP2014148568 A JP 2014148568A JP 2014148568 A JP2014148568 A JP 2014148568A JP 2014221816 A5 JP2014221816 A5 JP 2014221816A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- polymer
- poly
- cellulose
- excipients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 claims 38
- 239000008194 pharmaceutical composition Substances 0.000 claims 31
- 229920000642 polymer Polymers 0.000 claims 30
- 239000000546 pharmaceutical excipient Substances 0.000 claims 25
- 239000000203 mixture Substances 0.000 claims 19
- 229940088679 drug related substance Drugs 0.000 claims 18
- 229920002472 Starch Polymers 0.000 claims 13
- 239000008107 starch Substances 0.000 claims 13
- 235000019698 starch Nutrition 0.000 claims 13
- 229920001577 copolymer Polymers 0.000 claims 12
- 239000002131 composite material Substances 0.000 claims 11
- 229920000193 polymethacrylate Chemical class 0.000 claims 11
- 238000009472 formulation Methods 0.000 claims 10
- -1 sorbitan ester Chemical class 0.000 claims 10
- 229920002678 cellulose Polymers 0.000 claims 9
- 239000001913 cellulose Substances 0.000 claims 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 8
- 239000002202 Polyethylene glycol Substances 0.000 claims 8
- 229920001223 polyethylene glycol Polymers 0.000 claims 8
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 7
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 7
- 238000002156 mixing Methods 0.000 claims 7
- 239000004014 plasticizer Substances 0.000 claims 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 7
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 6
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 6
- 239000008101 lactose Substances 0.000 claims 6
- 239000000243 solution Substances 0.000 claims 6
- 239000004372 Polyvinyl alcohol Chemical class 0.000 claims 5
- 239000008186 active pharmaceutical agent Substances 0.000 claims 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 238000013329 compounding Methods 0.000 claims 5
- 230000009477 glass transition Effects 0.000 claims 5
- 238000009474 hot melt extrusion Methods 0.000 claims 5
- 229920000609 methyl cellulose Polymers 0.000 claims 5
- 235000010981 methylcellulose Nutrition 0.000 claims 5
- 239000001923 methylcellulose Substances 0.000 claims 5
- 229920000058 polyacrylate Chemical class 0.000 claims 5
- 229920002451 polyvinyl alcohol Chemical class 0.000 claims 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 4
- 229930006000 Sucrose Natural products 0.000 claims 4
- 229920013820 alkyl cellulose Polymers 0.000 claims 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims 4
- 239000008103 glucose Substances 0.000 claims 4
- 125000005456 glyceride group Chemical group 0.000 claims 4
- 235000011187 glycerol Nutrition 0.000 claims 4
- 239000002245 particle Substances 0.000 claims 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims 4
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims 4
- 235000012239 silicon dioxide Nutrition 0.000 claims 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 4
- 239000005720 sucrose Substances 0.000 claims 4
- 229920003067 (meth)acrylic acid ester copolymer Polymers 0.000 claims 3
- AVPDLWTUGIZJLH-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C([O-])=O.C[NH+](C)CCOC(=O)C(C)=C AVPDLWTUGIZJLH-UHFFFAOYSA-N 0.000 claims 3
- 244000215068 Acacia senegal Species 0.000 claims 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- 239000001856 Ethyl cellulose Substances 0.000 claims 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 3
- 229920002907 Guar gum Polymers 0.000 claims 3
- 229920000084 Gum arabic Polymers 0.000 claims 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 3
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 3
- 235000010489 acacia gum Nutrition 0.000 claims 3
- 239000000205 acacia gum Substances 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 3
- 229920002301 cellulose acetate Polymers 0.000 claims 3
- 229920006217 cellulose acetate butyrate Polymers 0.000 claims 3
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims 3
- 238000007906 compression Methods 0.000 claims 3
- 230000006835 compression Effects 0.000 claims 3
- 238000000748 compression moulding Methods 0.000 claims 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 235000019325 ethyl cellulose Nutrition 0.000 claims 3
- 229920001249 ethyl cellulose Polymers 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 claims 3
- 239000000194 fatty acid Substances 0.000 claims 3
- 229930195729 fatty acid Natural products 0.000 claims 3
- 238000011049 filling Methods 0.000 claims 3
- 238000009501 film coating Methods 0.000 claims 3
- 239000007888 film coating Substances 0.000 claims 3
- 150000004676 glycans Chemical class 0.000 claims 3
- 239000000665 guar gum Substances 0.000 claims 3
- 235000010417 guar gum Nutrition 0.000 claims 3
- 229960002154 guar gum Drugs 0.000 claims 3
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 3
- 229920003063 hydroxymethyl cellulose Polymers 0.000 claims 3
- 229940031574 hydroxymethyl cellulose Drugs 0.000 claims 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 3
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 claims 3
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 claims 3
- 238000001746 injection moulding Methods 0.000 claims 3
- 238000007909 melt granulation Methods 0.000 claims 3
- IWVKTOUOPHGZRX-UHFFFAOYSA-M methyl 2-methylprop-2-enoate;2-methylprop-2-enoate Chemical compound CC(=C)C([O-])=O.COC(=O)C(C)=C IWVKTOUOPHGZRX-UHFFFAOYSA-M 0.000 claims 3
- 239000003921 oil Substances 0.000 claims 3
- 235000019198 oils Nutrition 0.000 claims 3
- 229920001277 pectin Polymers 0.000 claims 3
- 235000010987 pectin Nutrition 0.000 claims 3
- 239000001814 pectin Substances 0.000 claims 3
- 229920001451 polypropylene glycol Polymers 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims 3
- 125000005591 trimellitate group Chemical group 0.000 claims 3
- 229920002554 vinyl polymer Polymers 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- 239000000230 xanthan gum Substances 0.000 claims 3
- 235000010493 xanthan gum Nutrition 0.000 claims 3
- 229920001285 xanthan gum Polymers 0.000 claims 3
- 229940082509 xanthan gum Drugs 0.000 claims 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims 2
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims 2
- 229920001817 Agar Polymers 0.000 claims 2
- 239000005995 Aluminium silicate Substances 0.000 claims 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 2
- 229920000858 Cyclodextrin Polymers 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- 239000005639 Lauric acid Substances 0.000 claims 2
- 239000005642 Oleic acid Substances 0.000 claims 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 2
- 229920000954 Polyglycolide Polymers 0.000 claims 2
- 229920001214 Polysorbate 60 Polymers 0.000 claims 2
- 229920001800 Shellac Polymers 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 claims 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims 2
- 239000008272 agar Substances 0.000 claims 2
- 235000010419 agar Nutrition 0.000 claims 2
- 150000005215 alkyl ethers Chemical class 0.000 claims 2
- 235000012211 aluminium silicate Nutrition 0.000 claims 2
- 239000000440 bentonite Substances 0.000 claims 2
- 229910000278 bentonite Inorganic materials 0.000 claims 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims 2
- 229920001400 block copolymer Polymers 0.000 claims 2
- 235000014121 butter Nutrition 0.000 claims 2
- 239000011575 calcium Substances 0.000 claims 2
- 229910052791 calcium Inorganic materials 0.000 claims 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 2
- 235000010216 calcium carbonate Nutrition 0.000 claims 2
- 229950008138 carmellose Drugs 0.000 claims 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 2
- 229960001231 choline Drugs 0.000 claims 2
- 230000000593 degrading effect Effects 0.000 claims 2
- 229960003964 deoxycholic acid Drugs 0.000 claims 2
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 claims 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 claims 2
- 229960004675 fusidic acid Drugs 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 235000001727 glucose Nutrition 0.000 claims 2
- 150000002334 glycols Polymers 0.000 claims 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims 2
- 229940033355 lauric acid Drugs 0.000 claims 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 2
- 229960002969 oleic acid Drugs 0.000 claims 2
- 229920003168 pharmaceutical polymer Polymers 0.000 claims 2
- 150000008105 phosphatidylcholines Chemical class 0.000 claims 2
- 229960000502 poloxamer Drugs 0.000 claims 2
- 229920001983 poloxamer Polymers 0.000 claims 2
- 229940065514 poly(lactide) Drugs 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 2
- 239000004208 shellac Substances 0.000 claims 2
- 229940113147 shellac Drugs 0.000 claims 2
- 235000013874 shellac Nutrition 0.000 claims 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims 2
- 235000020374 simple syrup Nutrition 0.000 claims 2
- 235000010413 sodium alginate Nutrition 0.000 claims 2
- 239000000661 sodium alginate Substances 0.000 claims 2
- 229940005550 sodium alginate Drugs 0.000 claims 2
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 claims 2
- 239000000454 talc Substances 0.000 claims 2
- 229910052623 talc Inorganic materials 0.000 claims 2
- 238000005054 agglomeration Methods 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 239000012512 bulk drug substance Substances 0.000 claims 1
- 239000007857 degradation product Substances 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 150000002191 fatty alcohols Chemical class 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002480 mineral oil Substances 0.000 claims 1
- 235000010446 mineral oil Nutrition 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 150000003014 phosphoric acid esters Chemical class 0.000 claims 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims 1
- 108091033319 polynucleotide Proteins 0.000 claims 1
- 102000040430 polynucleotide Human genes 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
- 230000007704 transition Effects 0.000 claims 1
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 1
- 239000008158 vegetable oil Substances 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95704407P | 2007-08-21 | 2007-08-21 | |
| US60/957,044 | 2007-08-21 | ||
| US5092208P | 2008-05-06 | 2008-05-06 | |
| US61/050,922 | 2008-05-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010522038A Division JP6073043B2 (ja) | 2007-08-21 | 2008-08-21 | 医薬品適用のための熱−動力学的混合 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014221816A JP2014221816A (ja) | 2014-11-27 |
| JP2014221816A5 true JP2014221816A5 (cg-RX-API-DMAC7.html) | 2015-01-15 |
Family
ID=40378995
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010522038A Active JP6073043B2 (ja) | 2007-08-21 | 2008-08-21 | 医薬品適用のための熱−動力学的混合 |
| JP2014148568A Withdrawn JP2014221816A (ja) | 2007-08-21 | 2014-07-22 | 医薬品適用のための熱−動力学的混合 |
| JP2016076558A Withdrawn JP2016121195A (ja) | 2007-08-21 | 2016-04-06 | 医薬品適用のための熱−動力学的混合 |
| JP2018226362A Withdrawn JP2019052173A (ja) | 2007-08-21 | 2018-12-03 | 医薬品適用のための熱−動力学的混合 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010522038A Active JP6073043B2 (ja) | 2007-08-21 | 2008-08-21 | 医薬品適用のための熱−動力学的混合 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016076558A Withdrawn JP2016121195A (ja) | 2007-08-21 | 2016-04-06 | 医薬品適用のための熱−動力学的混合 |
| JP2018226362A Withdrawn JP2019052173A (ja) | 2007-08-21 | 2018-12-03 | 医薬品適用のための熱−動力学的混合 |
Country Status (6)
| Country | Link |
|---|---|
| US (6) | US8486423B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2187968A4 (cg-RX-API-DMAC7.html) |
| JP (4) | JP6073043B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101835492B (cg-RX-API-DMAC7.html) |
| CA (3) | CA2697099C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009026461A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2155167A2 (en) | 2007-06-04 | 2010-02-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| US9545361B1 (en) * | 2011-07-25 | 2017-01-17 | Dispersol Technologies, Llc | Multiple speed process for preserving heat sensitive portions of a thermokinetically melt blended batch |
| CA2697099C (en) | 2007-08-21 | 2018-02-20 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| EP2309990B2 (en) | 2008-06-16 | 2017-03-15 | Pfizer Inc. | Drug loaded polymeric nanoparticles and methods of making and using same |
| EP2309991B1 (en) | 2008-06-16 | 2019-03-06 | Pfizer Inc | Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same |
| WO2010005726A2 (en) | 2008-06-16 | 2010-01-14 | Bind Biosciences Inc. | Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same |
| CA2741862C (en) * | 2008-10-31 | 2017-10-17 | Mahmoud A. Elsohly | Compositions containing delta-9-thc-amino acid esters and process of preparation |
| US8563041B2 (en) * | 2008-12-12 | 2013-10-22 | Bind Therapeutics, Inc. | Therapeutic particles suitable for parenteral administration and methods of making and using same |
| JP2012512175A (ja) * | 2008-12-15 | 2012-05-31 | バインド バイオサイエンシズ インコーポレイテッド | 治療薬を徐放するための長時間循環性ナノ粒子 |
| WO2010089132A1 (en) | 2009-02-06 | 2010-08-12 | Egalet A/S | Immediate release composition resistant to abuse by intake of alcohol |
| EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
| EP2509634B1 (en) | 2009-12-11 | 2019-03-06 | Pfizer Inc | Stable formulations for lyophilizing therapeutic particles |
| WO2011084513A2 (en) | 2009-12-15 | 2011-07-14 | Bind Biosciences, Inc. | Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers |
| WO2012116238A1 (en) * | 2011-02-23 | 2012-08-30 | Dispersol Technologies, Llc | PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-β-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS |
| CN102204868B (zh) * | 2011-05-18 | 2014-01-22 | 北京化工大学 | 采用多元辅料制备吲哚美辛速释制剂的热熔挤出工艺 |
| US9821283B1 (en) * | 2011-07-25 | 2017-11-21 | Dispersol Technologies, Llc | Direct probe sensed temperature method for speed change for heat sensitive portions of a thermokinetically melt blended batch |
| EA032943B1 (ru) | 2012-09-17 | 2019-08-30 | Пфайзер Инк. | Способ получения терапевтических наночастиц (варианты) и терапевтическая наночастица (варианты) |
| WO2015103230A1 (en) | 2013-12-31 | 2015-07-09 | Ascendia Pharmaceuticals, Llc | Pharmaceutical compositions for poorly water-soluble compounds |
| HUE043964T2 (hu) | 2014-03-14 | 2019-09-30 | Pfizer | Terápiás szert tartalmazó terápiás nanorészecskék és eljárás ezek elõállítására és alkalmazására |
| JP6537147B2 (ja) | 2014-03-18 | 2019-07-03 | 武田薬品工業株式会社 | 固体分散体 |
| HRP20211711T1 (hr) * | 2014-04-18 | 2022-02-18 | Dispersol Technologies, Llc | Postupak za više brzina i mješalica za očuvanje toplinski osjetljivih dijelova na toplinu šarže termokinetički otopljene smjese |
| US20170333404A1 (en) * | 2014-11-03 | 2017-11-23 | Dispersol Technologies, Llc | Improved formulations of vemurafenib and methods of making the same |
| EP3247334A1 (en) * | 2015-01-20 | 2017-11-29 | Merck Patent GmbH | Solid dispersions of compounds using polyvinyl alcohol as a carrier polymer |
| US10265301B2 (en) * | 2015-06-17 | 2019-04-23 | Dispersol Technologies, Llc | Formulations of deferasirox and methods of making the same |
| TWI799366B (zh) | 2015-09-15 | 2023-04-21 | 美商建南德克公司 | 胱胺酸結骨架平臺 |
| CA3022878C (en) * | 2016-05-09 | 2024-04-30 | Dispersol Technologies, Llc | Improved drug formulations |
| WO2017194578A1 (en) | 2016-05-13 | 2017-11-16 | Merck Patent Gmbh | Particle size and distribution of polymer for melt extrusion application |
| JP7376220B2 (ja) * | 2017-09-11 | 2023-11-08 | オースティンピーエックス リミテッド ライアビリティ カンパニー | 熱動力学的に溶融ブレンドされるバッチの熱感受性部分用の、直接プローブにより感知した温度による、速度変更のための方法 |
| AU2018335391A1 (en) * | 2017-09-22 | 2020-03-26 | AustinPx, LLC | Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof |
| LT3470133T (lt) | 2017-10-13 | 2021-03-10 | Dispersol Technologies, Llc | Tiesioginio temperatūros matavimo jutikliu būdas termokinetiškai lydyto mišinio partijos karščiui jautrių dalių maišymo greičiui keisti |
| CN109663524B (zh) * | 2017-10-13 | 2022-07-15 | 分散技术有限责任公司 | 用于热动力学熔体共混批次的热敏部分的速度改变的直接进样探头感测温度方法 |
| WO2019094688A1 (en) * | 2017-11-10 | 2019-05-16 | Dispersol Technologies, Llc | Improved drug formulations |
| EP3492070A1 (en) * | 2017-11-30 | 2019-06-05 | BIT Pharma GmbH | Process and device for preparing a solid dispersion |
| MX2020006518A (es) * | 2017-12-21 | 2020-10-28 | Danisco Us Inc | Gránulos de fusión en caliente, que contienen enzimas, que comprenden un desecante termotolerante. |
| US20200147032A1 (en) | 2018-11-14 | 2020-05-14 | Robert K. Prud'homme | Dihydromyricetin hot melt extrusion formulations and methods for forming them |
| WO2021108022A1 (en) * | 2019-11-30 | 2021-06-03 | Dispersol Technologies, Llc | Inclusion complexes of pharmaceuticals and cyclic oligomers |
| KR20220130698A (ko) * | 2019-12-20 | 2022-09-27 | 에피자임, 인코포레이티드 | Ezh2 억제제의 결정질 하이드로브로마이드 염, 이의 제조 및 암의 치료에 유용한 약학적 조성물 |
| WO2021202928A1 (en) | 2020-04-01 | 2021-10-07 | Board Of Regents, The University Of Texas System | Pharmaceutical compositions of niclosamide |
| AU2021391823A1 (en) | 2020-12-03 | 2023-06-29 | Battelle Memorial Institute | Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery |
| US20240108639A1 (en) * | 2020-12-11 | 2024-04-04 | Board Of Regents, The University Of Texas System | Compositions and methods of making cocrystals using dielectric heating with dispersive and distributive mixing |
| IL307454A (en) | 2021-04-07 | 2023-12-01 | Battelle Memorial Institute | Technologies for rapid design, construction, testing, learning to identify and use non-viral vectors |
| US20250000794A1 (en) * | 2021-07-27 | 2025-01-02 | Board Of Regents, The University Of Texas System | Improved drug processing methods to increase drug loading |
| WO2023034844A1 (en) | 2021-08-31 | 2023-03-09 | Board Of Regents, The University Of Texas System | Delayed release niclosamide formulation |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
| CN119453203A (zh) * | 2025-01-09 | 2025-02-18 | 山东百农思达生物科技有限公司 | 一种含杀虫单和阿维菌素的复合微乳制剂及其制备工艺 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2319478A1 (fr) * | 1975-07-30 | 1977-02-25 | Gen Electric | Extrudeuse et procede d'extrusion de materiaux thermoplastiques |
| US4230615A (en) * | 1978-11-21 | 1980-10-28 | Carlew Chemicals Limited | Process for controlled mixing in a high intensity mixer |
| US4628073A (en) * | 1984-10-03 | 1986-12-09 | Monsanto Company | Soft, rubbery, multiphase matrix material and methods for its production |
| US4789597A (en) * | 1987-01-12 | 1988-12-06 | Fetherstonhaugh & Co. | Incorporation of chemically reactive agents on resin particles |
| CA2108575C (en) * | 1991-04-16 | 2002-10-22 | Kouichi Nakamichi | Method of manufacturing solid dispersion |
| JP2516524B2 (ja) * | 1992-04-27 | 1996-07-24 | 大洋薬品工業株式会社 | 持続性製剤 |
| JPH07159587A (ja) | 1993-12-07 | 1995-06-23 | Hitachi Ltd | 樹脂性能モニタ |
| JPH07187998A (ja) * | 1993-12-27 | 1995-07-25 | Kao Corp | 錠剤の製造方法 |
| GB9422154D0 (en) | 1994-11-03 | 1994-12-21 | Euro Celtique Sa | Pharmaceutical compositions and method of producing the same |
| US5895790A (en) * | 1995-03-14 | 1999-04-20 | Good; Elmer | Thermosetting wide range polymer blends |
| DE19531067A1 (de) | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität |
| ATE255883T1 (de) * | 1996-05-20 | 2003-12-15 | Janssen Pharmaceutica Nv | Fungizide mittel mit verbesserter bioverfügbarkeit |
| US20010053791A1 (en) | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
| US6709146B1 (en) | 2000-07-28 | 2004-03-23 | David Little | Thermokinetic mixer and method of using |
| CA2448825C (en) * | 2001-06-22 | 2009-08-11 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drug |
| KR20040011248A (ko) * | 2002-07-30 | 2004-02-05 | 환인제약 주식회사 | 암로디핀의 고체분산체와 그 제조방법 및 그를 포함하는약학적 조성물 |
| CA2509958A1 (en) | 2003-02-03 | 2004-08-19 | Novartis Ag | Pharmaceutical formulation |
| GB0319797D0 (en) * | 2003-08-26 | 2003-09-24 | Leuven K U Res & Dev | Particle size reduction of poorly soluble drugs |
| US20050158376A1 (en) * | 2003-10-23 | 2005-07-21 | Sardi William F. | Dietary supplement and method of processing same |
| ATE495746T1 (de) | 2003-11-14 | 2011-02-15 | Ajinomoto Kk | Feste dispersion oder medizinisches festes dispersionspräparat eines phenylalanin-derivats |
| US20050258288A1 (en) | 2003-11-26 | 2005-11-24 | E. I. Du Pont De Nemours And Company | High pressure media milling system and process of forming particles |
| JP2005263758A (ja) * | 2004-03-22 | 2005-09-29 | Kirin Brewery Co Ltd | 非晶質のｎ−｛２−クロロ−４−［（６，７−ジメトキシ−４−キナゾリニル）オキシ］フェニル｝−ｎ’−プロピルウレア |
| KR101086254B1 (ko) * | 2004-11-04 | 2011-11-24 | 에스케이케미칼주식회사 | 생체이용률이 개선된 프란루카스트 고체분산체 조성물 및그 고체분산체의 제조방법 |
| CA2603235A1 (en) | 2005-03-28 | 2006-10-05 | Bioresponse, Llc | Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
| JP2006347939A (ja) * | 2005-06-15 | 2006-12-28 | Tokyo Printing Ink Mfg Co Ltd | 薬物高分子複合体の製造方法及び薬物高分子複合体 |
| JP4429262B2 (ja) * | 2005-12-09 | 2010-03-10 | 壽製薬株式会社 | フェノフィブラートの固体分散体 |
| US9545361B1 (en) * | 2011-07-25 | 2017-01-17 | Dispersol Technologies, Llc | Multiple speed process for preserving heat sensitive portions of a thermokinetically melt blended batch |
| CA2697099C (en) * | 2007-08-21 | 2018-02-20 | Board Of Regents, The University Of Texas System | Thermo-kinetic mixing for pharmaceutical applications |
| JP2012047227A (ja) | 2010-08-25 | 2012-03-08 | Nippon Steel & Sumikin Metal Products Co Ltd | ナット保持部材 |
| WO2012116238A1 (en) | 2011-02-23 | 2012-08-30 | Dispersol Technologies, Llc | PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-β-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS |
| US20170333404A1 (en) | 2014-11-03 | 2017-11-23 | Dispersol Technologies, Llc | Improved formulations of vemurafenib and methods of making the same |
-
2008
- 2008-08-21 CA CA2697099A patent/CA2697099C/en active Active
- 2008-08-21 EP EP08798412A patent/EP2187968A4/en not_active Ceased
- 2008-08-21 CN CN2008801123533A patent/CN101835492B/zh active Active
- 2008-08-21 CA CA3076115A patent/CA3076115C/en active Active
- 2008-08-21 CA CA2990445A patent/CA2990445C/en active Active
- 2008-08-21 US US12/196,154 patent/US8486423B2/en active Active
- 2008-08-21 JP JP2010522038A patent/JP6073043B2/ja active Active
- 2008-08-21 WO PCT/US2008/073913 patent/WO2009026461A2/en not_active Ceased
-
2013
- 2013-07-15 US US13/942,199 patent/US9339440B2/en active Active
-
2014
- 2014-07-22 JP JP2014148568A patent/JP2014221816A/ja not_active Withdrawn
-
2016
- 2016-04-06 JP JP2016076558A patent/JP2016121195A/ja not_active Withdrawn
- 2016-05-13 US US15/154,083 patent/US10022385B2/en active Active
-
2018
- 2018-06-19 US US16/012,025 patent/US10668085B2/en active Active
- 2018-12-03 JP JP2018226362A patent/JP2019052173A/ja not_active Withdrawn
-
2020
- 2020-05-05 US US16/866,676 patent/US11439650B2/en active Active
-
2022
- 2022-07-25 US US17/814,567 patent/US12023343B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014221816A5 (cg-RX-API-DMAC7.html) | ||
| RU2491918C2 (ru) | Способ грануляции из расплава | |
| EP2755637B1 (en) | Solid dispersion of poorly soluble compounds comprising crospovidone and at least one water-soluble polymer | |
| JP6730315B2 (ja) | 担体ポリマーとしてのポリビニルアルコールを用いた化合物の固体分散体 | |
| JP5546860B2 (ja) | 高結晶性治療化合物の固体分散体を製造するための方法 | |
| JP5443344B2 (ja) | タダラフィルを含む薬剤の製造の方法 | |
| JP5054000B2 (ja) | イマチニブおよび放出遅延剤を含む医薬組成物 | |
| JP7458440B2 (ja) | 改善された薬物製剤 | |
| CN106232144B (zh) | 固体分散体 | |
| WO2016111725A1 (en) | Dosage form incorporating an amorphous dgug solid solution | |
| JP2018517734A5 (cg-RX-API-DMAC7.html) | ||
| Madan et al. | Hot melt extrusion and its pharmaceutical applications. | |
| US20090148522A1 (en) | Heated roller compaction process for making pharmaceutical compositions | |
| JP2022177014A (ja) | Ｈｃｖを処置するための固体医薬組成物 | |
| EP2701689B1 (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
| JP2022141719A (ja) | Ｈｃｖを処置するための固体医薬組成物 | |
| JP7378393B2 (ja) | 改善された薬物製剤 | |
| WO2016128726A1 (en) | Method of producing a granulated composition | |
| JP2008526719A (ja) | 高圧処理により持続性放出制御型の固形医薬組成物を製造する方法 | |
| TR2021005753T (tr) | Seli̇neksorun yeni̇ kati di̇spersi̇yonlari | |
| TW201605437A (zh) | 固態醫藥組合物 | |
| WO2012159593A2 (en) | A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation |